Trixeo Aerosphere Europska Unija - hrvatski - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

AirBuFo Forspiro 320/9 mikrograma po dozi, prašak inhalata, dozirani Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

airbufo forspiro 320/9 mikrograma po dozi, prašak inhalata, dozirani

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - budezonid formoterolfumarat dihidrat - prašak inhalata, dozirani - 320 mikrograma + 9 mikrograma - urbroj: svaka isporučena doza (inhalacijska doza) sadrži 320 mikrograma budezonida i 9 mikrograma formoterolfumarata dihidrata

Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinalni gel Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinalni gel

lobsor pharmaceuticals ab, kalsängsgränd 10 d, uppsala, Švedska - levodopa karbidopa hidrat entakapon - intestinalni gel - urbroj: 1 ml gela sadrži 20 mg levodope, 5 mg karbidopa hidrata i 20 mg entakapona

DuoResp Spiromax 160 µg/1 doza+ 4.5 µg/1 doza prašak inhalata Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

duoresp spiromax 160 µg/1 doza+ 4.5 µg/1 doza prašak inhalata

pliva d.o.o.sarajevo - будесонид, formoterol - prašak inhalata - 160 µg/1 doza+ 4.5 µg/1 doza - 1 doza sadrži: 160 mikrograma budesonida 4,5 mikrograma formoterol fumarat dihidrata

Riltrava Aerosphere Europska Unija - hrvatski - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.